“showed a trend”

71%, p = 0.023; Figure 2A ), and showed a trend toward worse OS (5-year OS, 78% vs. 85%, p = 0.12; Figure 2B ).

In the group treated with carboplatin, the results showed a trend towards worse survival in TTF-1 − patients, with an OS of 1 month (95% CI: 0–2.3) compared to 4 months (95% CI: 0–10.4) in TTF-1 + patients (P=0.12).

(e) The ratio of open arm to total arm entries in the elevated plus maze showed a trend towards more open arm entries in J20 animals and a recovery of this in GluA2 G/G /J20 mice (Welch’s ANOVA W (3,29.15) = 2.12, p = 0.12; n’s : WT = 15, GluA2 G/G = 13, J20 = 16, GluA2 G/G /J20 = 14).

The current density of p.I1498M showed a 59% reduction, whereas the other variants did not show statistically significant modifications (although p.R1636Q showed a trend towards reduction, P = 0.12).

Another reason for conducting our study was the evidence in one RCT of a beneficial effect of levosimendan in the subgroup of patients with more severe reduction of LVEF (<25%) and in those undergoing isolated coronary artery bypass grafting (CABG); moreover, such RCTs showed a trend toward lower mortality at 90 days for levosimendan (4.7% vs placebo 7.1%, p = 0.12) [ 13 ].

Similarly, interventions using either probiotics or FMT were associated with an increased ORR (pooled OR = 1.62, P = 0.006) and showed a trend toward improved DCR (pooled OR = 1.74, P = 0.12).

Time spent doing reconstructive surgery did not statistically significantly influence overall breast aesthetic score but showed a trend toward higher scoring ( P = 0.12).

11 However, a prospective, phase II, B-F1RST study only showed a trend toward a PFS benefit (hazard ratio (HR) = 0.66; 90% confidence interval (CI): 0.42–1.02; P = .12) and an OS benefit (HR = 0.77; 90% CI: 0.41–1.43; P = .48). 12 Cancer is a genetic disease, and multiple genetic mutations may lead to resistance to therapy, including immunotherapy. 13 Recent studies r

Meta-regression showed a trend toward lower CBT efficacy for positive symptoms with a higher SZA disorder proportion (β = +0.10 SMD per 10% increase in AP; p = 0.12), though it was not statistically significant.

JDM patients receiving corticosteroid treatment showed a trend for a higher frequency of CD40L induced IL-10+ B cells (mean 19.5% vs 14.4%, p = 0.12).

TGV showed a trend-level effect for the shorter-than-average sleepers ( P = 0.12).

Fatigue showed a trend toward increased risk in the eptinezumab group (RR: 1.92, 95% CI 0.84–4.39, P = 0.12, I 2 = 41%), though it was not statistically significant.

Interestingly, only the presence of T-cell reactivity against CT antigens showed a trend towards correlation with CRs ( p = 0.12).

In contrast, in primary PCa, the Wnt pathway showed a trend towards increased activity (p = 0.12), and median FOXO activity was only slightly lower than in healthy tissue (p = 0.12) indicating that PI3K pathway activity was restricted to a subgroup of PCa.

reported significantly elevated post-exercise noradrenaline levels in the BFR group compared to controls ( p < 0.05), while growth hormone showed a trend toward elevation that did not reach statistical significance ( p = 0.12) [ 33 ].

Analysis of dependency of BIS-reduction on daytime showed a trend for HGSHS-5 (BIS total intervention) with 88.8 at noon vs. 90.5 in the morning and evening ( p = 0.12).

Interim OS data showed a trend towards benefit for both combination arms compared to CP alone (P=0.12 with CP + durvalumab versus CP; HR, 0.77; P=0.003 with CP + durvalumab + olaparib vs.

Scintillation counts showed a trend for increased 3 H-glucose signal in IRβ-expressing cells (Student’s t -test; p = 0.120), which exhibited ∼30% more uptake than control cells ( Figure 1E ).

RFS Kaplan‐Meier curves and log‐rank testing showed a trend towards decreased ( P = .120) survival probability in high ADI in the p16‐positive population with a 5‐year RFS of 64.5% relative to 76.8% in the low ADI group, though this difference was not significant ( Figure 2 ).

Among patients without CA, there were 10 (12.7%) cardiovascular deaths, 47 (59.5%) non-cardiovascular deaths, and 22 (27.8%) deaths from unknown causes. In-hospital outcomes did not differ between patients with CA at presentation or in the acute phase ( Table 2 ), though the latter showed a trend towards higher 60-day mortality (33.3% vs. 52.6%, P = 0.12).

Specifically, 7 days following immunization, vehicle-treated control mice showed a trend toward a greater DNP-specific IgM response than that of SU5416-treated mice (p = 0.12, Fig. 6B ).

Although the HIGH group showed a trend toward a higher CI post-ROSC, the differences did not reach statistical significance ( p = 0.12).

Multivariable analysis showed a trend toward decreased odds of an abnormal contrast swallow when a speech-language pathologist was present during the examination (OR =0.448, 95% CI: 0.165–1.215, P=0.12).

The inclusion of center-based cluster effects showed a trend towards ( P =0.12) improved model fit compared with fitting the same model using ordinary logistic regression with no clustering.

Similarly, there was no difference in survival between female and male smokers using Kaplan-Meier survival analysis although females showed a trend towards higher long-term mortality ( P = 0.12; Fig. 4 B).